BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○
BiohacksAI/Targets/PIK3R1/Compounds

Compounds That Target PIK3R1

phosphoinositide-3-kinase regulatory subunit 1 · 10 compounds in BiohacksAI corpus

PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1) is a biological target with 10 documented compound interactions in the BiohacksAI corpus. The compounds listed below have been identified through computational analysis of BindingDB binding assay data and PubMed literature. Each interaction is ranked by confidence score reflecting the breadth and strength of experimental evidence. This resource supports research into PIK3R1 modulation for therapeutic and biohacking applications.

View PIK3R1 target page →UniProt: P27986 ↗
Most Studied Compounds for PIK3R1
1
Wortmannin
300+
studies
2
Rapamycin
300+
studies
3
Quercetin
300+
studies
4
Alpelisib
227+
studies
5
Ly294002
11+
studies
6
Torin 1
10+
studies
All 10 Compounds — Ranked by Evidence
1
Ly 294002
4.84
confidence
2
Buparlisib
3.40
confidence
3
Pictilisibdrugage
2.83
confidence
4
Berzosertib
2.30
confidence
5
Wortmannin
300+
studies
2.08
confidence
6
Ly294002
11+
studies
1.95
confidence
7
Alpelisib
227+
studies
1.79
confidence
8
Rapamycin
300+
studies
1.10
confidence
9
Torin 1
10+
studies
1.10
confidence
10
Quercetin
300+
studies
0.69
confidence

The compounds above were identified through computational analysis of BindingDB binding assay data and PubMed literature for PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1). Confidence scores reflect the strength and breadth of experimental evidence.

Explore related resources: PIK3R1 target overview · All biological targets · Biological pathways

Data from BindingDB and PubMed. For research purposes only. Not medical advice.